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Abstract
Background: Robotic arm supports aim at improving the quality of life for adults with Duchenne muscular
dystrophy (DMD) by augmenting their residual functional abilities. A critical component of robotic arm supports is the
control interface, as is it responsible for the human-machine interaction. Our previous studies showed the feasibility of
using surface electromyography (sEMG) as a control interface to operate robotic arm supports in adults with DMD
(22-24 years-old). However, in the biomedical engineering community there is an often raised skepticism on whether
adults with DMD at the last stage of their disease have sEMG signals that can be measured and used for control.
Findings: In this study sEMG signals from Biceps and Triceps Brachii muscles were measured for the first time in a 37
year-old man with DMD (Brooke 6) that lost his arm function 15 years ago. The sEMG signals were measured during
maximal and sub-maximal voluntary isometric contractions and evaluated in terms of signal-to-noise ratio and
co-activation ratio. Beyond the profound deterioration of the muscles, we found that sEMG signals from both Biceps
and Triceps muscles were measurable in this individual, although with a maximum signal amplitude 100 times lower
compared to sEMG from healthy subjects. The participant was able to voluntarily modulate the required level of
muscle activation during the sub-maximal voluntary isometric contractions. Despite the low sEMG amplitude and a
considerable level of muscle co-activation, simulations of an elbow orthosis using the measured sEMG as driving
signal indicated that the sEMG signals of the participant had the potential to provide control of elbow movements.
Conclusions: To the best of our knowledge this is the first time that sEMG signals from a man with DMD at the
last-stage of the disease were measured, analyzed and reported. These findings offer promising perspectives to the
use of sEMG as an intuitive and natural control interface for robotic arm supports in adults with DMD until the last
stage of the disease.
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Introduction
People with Duchenne muscular dystrophy (DMD) lose
independent ambulation by the age of ten years, fol-
lowed by the development of scoliosis and loss of upper
extremity function during their teens, and develop severe
cardiomyopathies and respiratory problems during their
twenties [1]. Life expectancy of people with DMD has
substantially improved over the last five decades, due
to improvements in care, drugs, and the introduction of
home care technology, such as artificial ventilators [2]. As
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a result, there is currently a considerable group of adults
with DMD living with severe physical impairments and a
strong dependency on care up to their 30’s [3].
Several arm supports that compensate the weight of
the arms are commercially available and have shown
an increase of independence and quality of life for
teenagers with DMD [4]. However, in adults with DMD,
the decrease of muscle force combined with an increase
of passive joint-stiffness [5], reduces the effectiveness of
current arm supports [6, 7]. More advanced robotic arm
supports can provide extra assistance, and have the poten-
tial to enable adults with DMD to continue performing
activities of daily living, increasing their independence
and participation in social activities.
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In order to operate robotic arm supports, the user
needs to communicate his motion intention to the device
through a control interface. Currently, the only control
interface available for adults with DMD are hand joy-
sticks and switches, which are used to control wheelchairs
and external robotic arms. We consider that the use of
control interfaces that detect the motion intention from
physiological signals that are implicitly related to the sup-
ported motion can result in a more natural and intuitive
interaction with the robotic arm support. In this direc-
tion, we have developed and evaluated force and surface
electromyography (sEMG) based control interfaces [8, 9].
The ability for adults with DMD to use sEMG-based
control, a well-established control interface in upper-
extremity prosthetics [10], depends on the availability
and quality of their sEMG signals. EMG signals have
been used for decades in DMD patients for diagno-
sis and carrier detection [11]. These studies are mostly
based on invasive needle EMG recordings. Studies with
sEMG in boys and men with Duchenne are less com-
mon and most of them report measurements of lower
extremity, facial or oral muscles [12–14]. From a com-
prehensive literature review we found that Priez et. al.
[15], Bowen et. al [16], Kumangai and Yamada [17],
Fascarelli et al. [18], Lobo-Prat et al. [9], and Janssen et al.
[19] measured sEMG signals from upper extremity mus-
cles in subjects with DMD aged between 5 to 24 years.
To the best of our knowledge there are no published
studies that report the measurement of upper-extremity
sEMG signals in men with DMD older than 24 years,
which is the period when robotic arm supports are most
needed.
In a previous study [9], we showed that both sEMG-
and force-based control interfaces were feasible solutions
for the control of elbow movements in adults with DMD
(22-24 years-old). Force-based control was experienced
as fatiguing by all participants, a fact that indicates that
sEMG-based control is probably the only viable interface
for adults with DMD at the last stage of the disease. How-
ever, in the biomedical engineering community there is
an often raised skepticism over adults with DMD at the
last stage of their disease (Brooke score 6) having sEMG
signals that can be measured and used for control. As
a consequence, development of assistive devices for this
group of patients is getting low attention. We think that
this skepticismmight be based on a wrong pre-conception
and that it is thus important to investigate if sEMG signals
from upper-extremity muscles of men with DMD at the
last stage of the disease are measurable and can be used
for control.
DMD patients at the last stage of their disease are very
rare and getting them involved in any study is difficult and
delicate, because they easily get overwhelmed by the exer-
cises. As a consequence, conducting tests with even just a
few of these subjects is very unlikely and general conclu-
sions will have to be drawn from a number of independent
studies. We were able to get the kind collaboration of a
37 year-old man with DMD for this study to evaluate his
sEMG signals from upper-extremity biceps and triceps
muscles. Albeit results from only one subject are insuf-
ficient to draw general conclusions, they are relevant to
be communicated because of their exceptional nature and
will encourage similar studies.
While we hypothesized that the neural activation of the
muscle is still measurable in men with DMD that have
lost their arm function long time ago (DMD is a dis-
ease affecting the contraction of the muscle cells only), we
expected their sEMG signals to have a much lower ampli-
tude than in the case of healthy individuals: the infiltration
of fatty and connective tissue in the muscle is known to
increase the electrical impedance [20]. The quality of the
sEMG signals was evaluated in terms of signal-to-noise
ratio (SNR) and co-activation ratio (CAR). Additionally,
we evaluated the feasibility of decoding the user’s move-
ment intention from the measured sEMG simulating a
sEMG-controlled elbow orthosis.
Methods
Participant
A 37 year-old man with DMD participated in this study.
The participant was classified according to the Brooke
upper extremity function scale [21] with a score of 6 (i.e.
no arm/hand function was left) and lost his arm function
long time ago: shoulder movements more than 20 years
ago, and elbow flexion-extension more than 15 years ago.
He was able to control an electric wheelchair with a highly
sensitive joystick and several push buttons that were oper-
ated using residual motion of the fingers of both hands.
No other functional tasks were possible with his arms or
hands. The participant also presented joint contractures
caused by the disuse of the arms, which severely limited
the range-of-motion of all the upper-extremity joints.
Signal acquisition and processing
The sEMG signals were measured from the Biceps Brachii
and Triceps Brachii muscles of the right arm, which orig-
inally was the dominant arm. Two 99.9% Ag parallel bars
electrodes (contact: 10 mm x 1 mm each) spaced 10 mm
apart (Bagnoli DE-2.1. Delsys; Boston, Massachusetts)
were placed in parallel with the muscle fibers following
to the SENIAM recommendations [22] and manual mus-
cle exploration, after the skin was shaved and scrubbed
clean. The signals were amplified with a Delsys Bagnoli-
16Main Amplifier and ConditioningUnit (Delsys; Boston,
Massachusetts) with a bandwidth of 20 to 450 Hz and a
gain of 1000.
The sEMG signals were measured with a data acqui-
sition card with a sampling frequency of 1 kHz and
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16 bit resolution. The offset of the raw sEMG sig-
nals was removed on-line using a fourth-order But-
terworth high-pass filter with a cutoff frequency of
20 Hz. Subsequently the signals were full-wave recti-
fied and smoothed using a second-order low-pass But-
terworth filter with a cutoff frequency of 1 Hz to
obtain the signal envelope. The envelopes were used
for the visual feedback during the maximal voluntary
isometric contractions (MVIC) and sub-maximal vol-
untary isometric contractions (SVIC), for the analy-
sis of the CAR, and for the simulation of the elbow
orthosis.
Measurement protocol
The participant was asked to perform a series of MVICs
and SVICs with his biceps and triceps muscles. TheMVIC
were measured to investigate the maximal signal ampli-
tude, and the SVIC were measured to investigate if the
participant could voluntarily modulate the intensity of the
muscle activation. Since the participant had not been able
to voluntarily flex and extend his elbow joint for a long
time, the examiner passively moved his elbow joint and
applied pressure against the intended movement to famil-
iarize the subject with the task. For the MVIC measure-
ments the researcher asked the participant to maximally
flex and extend his elbow during three seconds, three
times for each muscle. For the SVIC measurements the
subject was asked to reach three activation levels (20%,
40% and 80% of MVIC) during three seconds for each
muscle. Note that the actual activation levels achieved by
the participant were slightly different from these target
levels (see “Results” section). Having three activation lev-
els, only one run for each level could be performed to
avoid overwhelming the participant with too long a ses-
sion. All measurements were guided with real-time visual
feedback of the sEMG envelopes displayed on a computer
screen. For the SVICs the researcher pointed at three
levels on the computer screen used for visual feedback.
Between each muscle contraction the participant rested
during five to ten seconds and between each series of
MVIC or SVIC tasks the participant rested during five to
ten minutes.
Data analysis
The quality of the sEMG signals was evaluated in terms of
the SNR and the CAR. Additionally, the measured sEMG
signals were used to drive a simulated elbow orthosis
to evaluate the feasibility of using the sEMG signals for
control purposes.
Signal-to-noise ratio
The SNR of the biceps (SNRb) and of the triceps (SNRt)
were calculated by taking the ratio between the power of
the root-mean-squared amplitude of the raw sEMG signal
(RMSb, RMSt) during the threeMVIC and SVICmeasure-
ments, and the power of the RMS amplitude of the raw
sEMG signal during a resting period, which represented
the noise level (RMSnb, RMSnt):
SNRb =
( RMSb
RMSnb
)2
, SNRt =
( RMSt
RMSnt
)2
. (1)
The SNR of the biceps (SNRbdB ) and of the triceps
(SNRtdB ) expressed in decibels (dB) was calculated using:
SNRbdB =10log10
(RMSb
RMSnb
)2
, SNRtdB =10log10
(RMSt
RMSnt
)2
.
(2)
The highest RMS value found within the three repeti-
tions of the MVIC measurement was used to normalize
the EMG signals of the biceps and triceps muscles for the
CAR calculation.
Co-activation Ratio
Similarly to the SNR, we evaluated the involuntary acti-
vation of the antagonistic muscle by calculating the CAR
of the biceps (CARb) and triceps (CARt). The CAR was
defined as the ratio between the RMS amplitude of the
normalized sEMG signal envelope of the agonist muscle
(RMSNb, RMSNt), and the RMS amplitude of the nor-
malized sEMG signal envelope of the antagonist muscle
(RMSNt , RMSNb) during the three MVIC and SVIC mea-
surements (Eq. 3). A high CAR value indicates a high level
of co-activation while a low CAR value indicates that a low
level co-activation is present.
CARb = RMSNtRMSNb , CARt =
RMSNb
RMSNt
(3)
The normalized signal envelopes of the biceps (RMSNb)
and triceps (RMSNt) were calculated by dividing the RMS
value of the signal envelope (RMSEb, RMSEt) by the RMS
value of the signal envelope of the MVIC (RMSEbMVIC ,
RMSEtMVIC ; Eq. 4). Note that the RMS value of the noise
envelope (RMSEnb, RMSEnt) was subtracted from signal
envelopes before calculating RMSNb and RMSNt .
RMSNb = (RMSEb − RMSEnb)RMSEbMVIC − RMSEnb)
,
RMSNt = (RMSEt − RMSEnt)RMSEtMVIC − RMSEnt)
(4)
Elbow orthosis simulation
In order to evaluate the feasibility of using the mea-
sured sEMG signals for control purposes, we performed
an off-line simulation (i.e. open-loop control) of a sEMG-
controlled elbow orthosis. This method was chosen
because the high intrinsic stiffness and contractures
present in the elbow joint of the participant prevented the
use of a real robotic elbow orthoses.
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The sEMG-based control method implemented in the
simulation and described in this subsection was the same
used in our previous study [9] were elbow movements of
adults with DMD were supported with an elbow orthosis.
An estimation of the elbow torque (τˆe) was obtained by
multiplying the signal envelops of the biceps and triceps
sEMG signals (Eb, Et) by a mapping gain (Kb, Kt) and sub-
sequently subtracting the triceps signal from the biceps
signal:
τˆe = EbKb − EtKt . (5)
Note that a fix offset resulting from the sEMG signal
noise was removed from the signal envelopes to obtain
Eb and Et . The offset value was calculated by taking the
mean value of the signal envelope during three seconds
while the participant was relaxed. For the simulation, the
signals measured during the MVIC of the biceps and of
the triceps (shown in Fig. 1) were concatenated and used
as Eb and Et . The mapping gains Kb = 2 Nm/mV and
Kt = 0.72 Nm/mV were chosen to properly distinguish
biceps from triceps activation and to obtain a symmetric
elbow flexion-extension movement.
The estimated elbow torque was then used as input
for an admittance model that rendered the dynamics
of a mass-damper system and had as output the elbow
angle (θe):
θe(s) = 1
(Ivs2 + Bvs) τˆe(s), (6)
where Iv and Bv represent the virtual mass and damp-
ing parameters of the admittance model respectively, and
s is the Laplace transform variable. Note that in a real
elbow orthosis, the elbow angle (θe; or the angular veloc-
ity) resulting from Eq. (6) would be used as reference
signal for a low-level position (or velocity) controller of
the elbow orthosis as in [9]. The simulation was carried
out with Iv = 4 · 10−3 kg m2 and Bv = 1 · 10−3 Nm
s/rad respectively, which resulted in a motion close to the
natural range of the elbow joint. In a real elbow orthosis
the interface dynamics and the mapping gains would be
chosen to the convenience of the user.
Results
Maximal voluntary isometric contractions (MVIC)
The raw sEMG signals of theMVICs during three seconds
presented maximum amplitudes of 0.01 and 0.015 mV for
biceps and triceps muscles respectively (Fig. 1). The RMS
values of the sEMG signals of the agonist muscle were
higher for the triceps (MVICt in Fig. 1) than for the biceps
(MVICb in Fig. 1) in all three repetitions, with an average
value of 0.0025 mV for the triceps and 0.0019 mV for the
biceps. Also, the mean SNR (Fig. 4a) of the triceps during
MVICwas double than that of the biceps (SNRt : 4.16±0.5
(12.4±1 dB); SNRb : 2.17±0.5 (6.7±2 dB); Fig. 4a and b).
Both RMS and SNR values were lower for the biceps than
a b
Fig. 1 Raw sEMG signals during three maximal voluntary isometric contractions (MVIC) of biceps and triceps muscles. a Agonist activation of biceps
in blue; signal of antagonist muscle (triceps) in red. RMS values for each MVIC of the biceps:MVICb1=0.0021 mV,MVICb2=0.0016 mV,MVICb3=0.0019
mV. b Agonist activation of triceps in red; signal of antagonist muscle (biceps) in blue. RMS values for each MVIC of the triceps:MVICt1=0.0024 mV,
MVICt2=0.0026 mV,MVICt3=0.0025 mV
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for the triceps which could indicate a higher muscle atro-
phy of the biceps (infiltration of fatty and connective tissue
in the muscle, which degrades the sEMG signal).
Mean CAR values for both muscles during the MVICs
were 0.55 ± 0.2 for the biceps and 0.44 ± 0.2 for the
triceps (CARb and CARt respectively in Eq. 3), which indi-
cated profound co-activation of the antagonist muscle,
even more so for the biceps than for the triceps (Fig. 4c).
Sub-maximal voluntary isometric contractions (SVIC)
When performing the SVICs, the participant was able to
generate sEMG signals that followed the level of effort
demanded by the task (Figs. 2 and 3), indicating that the
participant could voluntarily modulate the required level
of muscle activation. The SNR of the SVICs increased for
both biceps and triceps muscles with the increase of SVIC
level (Fig. 4a), as expected because of the raise in signal
amplitude. In agreement with the results of the MVICs,
the SNRs of the triceps muscle were higher than the ones
of the biceps muscle for all conditions.
The CARs of the biceps muscle were higher than the
CARs of the triceps muscle for all levels of SVIC (Fig. 4c).
While the CARs of the triceps muscle presented values
close to 0.5 for all SVICs (with the exception of the 20%
SVIC level) the CARs of the bicepsmuscle presentedmore
variability over activation levels: the CAR of the 20% SVIC
level was above 1.5, the CAR of the 40% SVIC level and of
100% was close to 0.5, and the CAR of the 80% SVIC level
was close to 1.
Elbow orthosis simulation
Figure 5a and b show the raw and the envelope of the
sEMG signals respectively used as input for the simula-
tion. Figure 5c shows the estimated muscle torque calcu-
lated by multiplying the signal envelope with the mapping
gains Kb and Kt . Note that after applying the mapping
gains, the biceps signal is larger than the triceps signal
for the first half of the movement and the triceps sig-
nals is larger then the biceps signal for the second half
of the movement. Figure 5d shows the estimated elbow
torque resulting from the difference between the biceps
and triceps muscle torques. Figure 5e presents the output
of the admittance controller and shows that the simulated
system responded with a positive angular velocity during
a
b
Fig. 2 Envelope of the sEMG signals during sub-maximal voluntary isometric contractions of biceps muscle. a Envelope of the sEMG signals
measured during the 20%, 40% and 80% SVICb of the biceps muscle in blue. Envelope of the antagonist muscle (triceps) in dashed red. b Boxplots of
the 3000 data points (i.e. 3 seconds) measured for each of the SVIC levels shown in A. In blue the boxplots of the biceps sEMG signals and in faded
red the boxplots of the antagonist muscle (triceps). Note that the noise level of the sEMG signal during relaxation is also shown
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a
b
Fig. 3 Envelope of the sEMG signals during sub-maximal voluntary isometric contractions of triceps muscle. a Envelope of the sEMG signals
measured during the 20%, 40% and 80% SVICt of the triceps muscle in red. Envelope of the antagonist muscle (biceps) in dashed blue. b Boxplots of
the 3000 data points (i.e. 3 seconds) measured for each of the SVIC levels shown in A. In red the boxplots of the triceps sEMG signals and in faded
blue the boxplots of the antagonist muscle (biceps). Note that the noise level of the sEMG signal during relaxation is also shown
the first part of the movement (biceps activation) and a
negative angular velocity during the second part (triceps
activation). The integral of this angular velocity is shown
in Fig. 5f, which indicates that the simulated orthosis
would successfully support an elbow flexion and exten-
sion movement of 1 rad in 20 s with a maximum speed of
±0.2 rad/s under the control of the realistic sEMG signals
shown in Fig. 5a. Note that the apparent delay between the
muscle activation signal and the initiation of the move-
ment is due to the phase lag of the second order dynamics
of the admittance model with low mass and damping
Eq. (6). In our previous studies [9, 23], we have seen that
these kind of interaction dynamics are usable by adults
with DMD.
Figures 6 and 7 in Additional file 5 show the results
obtained with the same elbow orthosis model but using
all three repetitions of the MVICs and of the SVICs
as input signal. These results indicate that it is possi-
ble to distinguish three flexion movements following the
three MVICs or SVICs of the biceps, and three extension
movements following the three MVICs or SVICs of the
triceps. Differences in angular velocity and displacement
of the movements are due to differences in amplitude
and duration of each of the MVICs or SVICs signals.
Additional files 1, 2, 3, and 4 contain the datasets of sEMG
signals used in this study.
Discussion
Our results revealed the profound deterioration of the
upper-extremity muscles of the 37-year-old man with
DMD. The maximum amplitudes of the sEMG signals of
the participant were 100 times lower than those typical of
healthy individuals (i.e. our measurements of 0.01 mV vs.
the 1 mVmeasured in healthy individuals [24]). These low
signal amplitudes implied low SNRs. We also found pro-
found involuntary activation of the antagonistic muscle as
revealed by the measured CARs, which could be caused
by the disuse of the arms. Note that arm immobilizations
of 12 h are sufficient to significantly reduce motor perfor-
mance in healthy subjects [25]. Probably with practice the
participant would learn to isolate better the activation of
the muscles.
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a
b
c
Fig. 4 Signal-to-noise ratio (SNR) and co-activation ratio (CAR) for the biceps and triceps sEMG signals as function of activation level. a
Signal-to-noise ratios of the biceps (blue) and triceps (red) sEMG signals during the three SVIC and MVIC. b Signal-to-noise ratios of the biceps (blue)
and triceps (red) sEMG signals during the three SVIC and MVIC expressed in decibels (dB). c Co-activation ratios of the biceps (blue) and triceps (red)
sEMG signals during the three SVIC and MVIC. Note that the error bar is only shown for the MVIC as this measurement was repeated three times
Despite the deterioration of the muscles, we cannot
underestimate the fact that sEMG signals from the biceps
and triceps muscles were still measurable in a 37-year-
old man with DMD that presented considerable muscle
deterioration since 20 years ago and completely lost his
arm function 15 years ago. Our results also indicate that
the participant was able to adjust his voluntary isometric
contractions as demanded by the exercises.
The relevance of detecting measurable upper-extremity
sEMG signals in adults with DMD at the late-stage of
the disease extends beyond its clinical interest. sEMG
signals can be used to detect the users’ motion inten-
tion and control rehabilitation or assistive devices, which
have the potential to delay the disease progression and
increase the quality of life for men with DMD [26, 27].
On this regard, our simulation, which used the mea-
sured sEMG signals as input, suggests that, if the high
degree of joint stiffness and contractures were not present,
the participant could control an active elbow orthosis
to perform flexion-extension movements with the same
proportional sEMG-based control method used in our
previous study [9]. The angular velocity and displacement
obtained by the simulation indicated that it is possible
to detect the elbow flexion/extension movement inten-
tion of the user from the measured sEMG of the biceps
and the triceps muscle. Nevertheless, these results need
to be regarded with caution since we did not test the
performance of the sEMG-based control using a real
system.
Currently, the use of robotic elbow orthoses in adults
with DMD in the last stage of the disease is not an option
due to the high intrinsic stiffness and joint contractures.
However, the use of arm supports, would allow people
with DMD to keep using their arms and therefore con-
tribute to the delay of their functional deterioration. We
expect that in the future, boys and men with DMD will
use arm supports from an early age, which would preserve
the range of motion of their joints and potentially benefit
from the use of sEMG-controlled arm supports until the
last stage of the disease.
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a
b
c
d
e
f
Fig. 5 Simulation of the sEMG-controlled elbow orthosis. a Raw sEMG signals used as input for the simulation. Specifically the first (MVICb1) and
third (MVICt3) MVIC attempts of the biceps (blue) and triceps (red). b Envelopes of the raw sEMG signals of the biceps (blue) and triceps (red). c
Estimated muscle torque of the biceps (blue) and triceps (red) obtained by multiplying the envelopes multiplying by the mapping gains Kb and Kt . d
Estimated elbow torque calculated by subtracting the estimated triceps torque from the estimated biceps torque (Eq. 5). e Angular velocity
resulting from the admittance model (Eq. 6). f Elbow angle displacement resulting from the integral of the angular velocity (Eq. 6)
Conclusions
The results of the present case study indicate that sEMG
signals from the biceps and triceps muscles were very
deteriorated but still measurable in a 37 year-oldman with
DMD that lost his arm function several years ago. Also,
the participant was able to adjust his muscle activation
level as demanded by the SVIC tasks. To the best of our
knowledge this is the first time that sEMG signals from a
man with DMD at the last-stage of the disease were mea-
sured and reported. Despite the muscle deterioration, the
measured signals could be successfully used as input for
the control of a simulated elbow orthosis. These results
offer promising perspectives to the use of sEMG as an
intuitive and natural control interface for assistive devices
in adults with DMD until the last stage of the disease, pro-
vided that the use of assistive devices since an early stage
of the disease reduce joint stiffness and contractures.
Results from only one subject are insufficient to draw
general conclusions, but the difficulties to involve partic-
ipants with DMD in the last stage of the disease make
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the inclusion of several patients in one single study highly
complicated. Thus, sufficient evidence should come by
integrating independent studies performed in different
laboratories. We hope that the results presented in this
Short Report will start breaking the current general opin-
ion that sEMG signals are too weak in DMD patients at
the last stage of the disease to be used for control, and
will encourage similar studies in other parts of the world,
finally leading to better assistive devices for adults with
DMD.
Additional files
Additional file 1: Raw sEMG signals during the biceps MVICs. MAT file
containing two vectors of data (30001x1) of the raw sEMG signals of the
biceps (EMGb) and the triceps (EMGt). Data was measured at 1 kHz.
(MAT 421 kb)
Additional file 2: Raw sEMG signals during the triceps MVICs. MAT file
containing two vectors of data (30001x1) of the raw sEMG signals of the
biceps (EMGb) and the triceps (EMGt). Data was measured at 1 kHz.
(MAT 424 kb)
Additional file 3: Raw sEMG signals during the biceps SVICs. MAT file
containing two vectors of data (59806x1) of the raw sEMG signals of the
biceps (EMGb) and the triceps (EMGt). Data was measured at 1 kHz.
(MAT 854 kb)
Additional file 4: Raw sEMG signals during the triceps SVICs. MAT file
containing two vectors of data (59706x1) of the raw sEMG signals of the
biceps (EMGb) and the triceps (EMGt). Data was measured at 1 kHz.
(MAT 853 kb)
Additional file 5: Additional results of the simulation of the
sEMG-controlled elbow orthosis. PDF file showing two figures with
additional results of the simulation of the sEMG-controlled elbow orthosis.
(PDF 899 kb)
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